Cargando…

A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population

Human immunodeficiency virus (HIV) is a chronic infectious disease currently requiring lifelong antiretroviral therapy (ART). People living with HIV (PLWH) face an increased risk of comorbidities associated with aging, chronic HIV, and the toxicity arising from long-term ART. A literature review was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chawla, Anita, Wang, Christina, Patton, Cody, Murray, Miranda, Punekar, Yogesh, de Ruiter, Annemiek, Steinhart, Corklin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986685/ https://www.ncbi.nlm.nih.gov/pubmed/29761330 http://dx.doi.org/10.1007/s40121-018-0201-6

Ejemplares similares

Patient Experience and Views on Antiretroviral Treatment—Findings from the Positive Perspectives Survey
por: Young, Benjamin, et al.
Publicado: (2017)

Improving access to antiretrovirals in China: economic analyses of dolutegravir in HIV-1 patients
por: Punekar, Yogesh Suresh, et al.
Publicado: (2019)

Pitfalls of Antiretroviral Therapy: Current Status and Long-Term CNS Toxicity
por: Rudd, Harrison, et al.
Publicado: (2022)

Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens
por: Serrano-Villar, Sergio, et al.
Publicado: (2022)

2484. Patient Reported Outcomes After Switching to a 2-Drug Regimen of Dolutegravir + Rilpivirine: Week 148 Results from the Sword-1 and Sword-2 Studies
por: Oglesby, Alan, et al.
Publicado: (2019)

“It made me more confident that I have it under control”: Patient and provider perspectives on moving to a two-drug ART regimen in the United States and Spain
por: Davis, Wendy, et al.
Publicado: (2020)

Role of Serologic and Molecular Diagnostic Assays in Identification and Management of Hepatitis C Virus Infection
por: Cloherty, Gavin, et al.
Publicado: (2016)

2488. Virologic Failure in ART Naïve Patients Initiating on a Dolutegravir or Elvitegravir-Based Regimen
por: Wohlfeiler, Michael, et al.
Publicado: (2019)

1329. Experiences and Emotional Challenges of Antiretroviral Treatment (ART)—Findings from the Positive Perspectives Study
por: De Los Rios, Patricia, et al.
Publicado: (2019)

Commentary: Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens
por: Llibre, Josep M., et al.
Publicado: (2022)

Immune-checkpoint inhibitors: long-term implications of toxicity
por: Johnson, Douglas B., et al.
Publicado: (2022)

Response to Commentary: Long-term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens
por: Serrano-Villar, Sergio, et al.
Publicado: (2022)

Effectiveness of four antiretroviral regimens for treating people living with HIV
por: Cavalcanti, Aracele Tenório de Almeida e, et al.
Publicado: (2020)

Antiretroviral regimen complexity as a predictor of adherence
por: Boyle, C, et al.
Publicado: (2010)

Comparison of Antiretroviral Regimens: Adverse Effects and Tolerability Failure that Cause Regimen Switching
por: Kim, Min Jung, et al.
Publicado: (2015)

Total body irradiation as part of conditioning regimens in childhood leukemia—long-term outcome, toxicity, and secondary malignancies
por: Gruen, Arne, et al.
Publicado: (2021)

Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care
por: Punekar, Yogesh Suresh, et al.
Publicado: (2015)

A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β(2)-Agonist (LABA) Combinations in COPD
por: Sion, Katya Y. J., et al.
Publicado: (2017)

Comparative efficacy of long-acting muscarinic antagonist monotherapies in COPD: a systematic review and network meta-analysis
por: Ismaila, Afisi Segun, et al.
Publicado: (2015)

Effectiveness and safety of dolutegravir two‐drug regimens in virologically suppressed people living with HIV: a systematic literature review and meta‐analysis of real‐world evidence
por: Punekar, Y S, et al.
Publicado: (2021)

Effectiveness of antiretroviral therapy in the single-tablet regimen era
por: Costa, Juliana de Oliveira, et al.
Publicado: (2018)

Towards an ideal antiretroviral regimen for the global HIV epidemic
por: Grinsztejn, Beatriz, et al.
Publicado: (2017)

Long-term Virological Outcome in Children on First-line Antiretroviral Therapy in India
por: Chandrasekaran, Padmapriyadarsini, et al.
Publicado: (2017)

Self-Reported Long-Term Antiretroviral Adherence: A Longitudinal Study Among HIV Infected Pregnant Women in Mpumalanga, South Africa
por: Ramlagan, Shandir, et al.
Publicado: (2019)

Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy
por: Easterbrook, Philippa J, et al.
Publicado: (2010)

Clinical Features of Cytomegalovirus Retinitis in HIV Infected Patients
por: Tang, Yang, et al.
Publicado: (2020)

Designing a Predictive Model for Antiretroviral Regimen at the Antiretroviral Therapy Center in Chiro Hospital, Ethiopia
por: Nemomsa, Gadissa, et al.
Publicado: (2021)

Nuke-sparing regimens as a main simplification strategy and high level of toxicity resolution after antiretroviral switch: the SWITCHART Study
por: Carrero-Gras, Ana, et al.
Publicado: (2014)

2499. Perceptions of and Preferences for Oral or Long-Acting Injectable Antiretroviral Treatment Regimens in the United States and Canada
por: Garris, Cindy, et al.
Publicado: (2019)

Time to virologic failure for patients taking their first antiretroviral regimen and the subsequent resistance profiles
por: Crouzat, Frederic, et al.
Publicado: (2014)

Long-term virological outcome in children receiving first-line antiretroviral therapy
por: Chandrasekaran, Padmapriyadarsini, et al.
Publicado: (2018)

Duration of antiretroviral regimens in treatment-experienced patients in clinical practice
por: Vilaplana, Vicente Escudero, et al.
Publicado: (2010)

Medication Possession Ratio Predicts Antiretroviral Regimens Persistence in Peru
por: Salinas, Jorge L., et al.
Publicado: (2013)

Long-term virologic and immunologic responses on darunavir/ritonavir – containing regimens among highly antiretroviral therapy-experienced patients: 7-year follow-up of a prospective cohort study in São Paulo, Brazil
por: Vidal, José E., et al.
Publicado: (2017)

Antiretroviral Treatment Simplification With 2-Drug Regimens: Impact of Transmitted Drug Resistance Mutations
por: Kessler, Harald H, et al.
Publicado: (2019)

Antiretroviral Regimen and Suboptimal Medication Adherence Are Associated With Low-Level Human Immunodeficiency Virus Viremia
por: Konstantopoulos, Christina, et al.
Publicado: (2015)

Incidence rate of modifying or discontinuing first combined antiretroviral therapy regimen due to toxicity during the first year of treatment stratified by age
por: Torres, Thiago Silva, et al.
Publicado: (2013)

Treatment outcomes and HIV drug resistance of patients switching to second-line regimens after long-term first-line antiretroviral therapy: An observational cohort study
por: Cao, Pi, et al.
Publicado: (2018)

Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 Patients
por: Wang, Zhenyan, et al.
Publicado: (2021)

Perceptions of Long-Acting Injectable Antiretroviral Treatment Regimens in a United States Urban Academic Medical Center
por: Koren, David E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h2jli03d7shj76udjjsqisl8nd